Human T-lymphotropic virus type II (HTLV-II) is a human retrovirus which is endemic in
Amerindian and pygmy tribes. Molecular subtypes show geographic segregation consistent …

The finding of dual HTLV-I and HIV-1 infection in populations at risk for AIDS raises the
possibility that interaction between the two viruses might have clinical significance. It was …

BACKGROUND: HTLV-1/2 diagnosis in high-risk populations from São Paulo, Brazil has
been problematic due a high proportion of seroindeterminate results. OBJECTIVES: To …

Serological studies on 926 blood samples from 703 Brazilian Kayapo (Cayapo) Indians
showed, by conventional definition of HTLV seropositivity, a 28% prevalence of human T …

Background: Retrovirus infections among injecting drug users (IDUs), a core at-risk
population for both HIV-1 and HTLV-I/II infections in Brazil, were assessed within an ongoing …

Human T-lymphotropic virus type III (HTLV-III) is a recently discovered retrovirus with tropism
and cytotoxicity for the OKT4+ lymphocytes that are depleted in the acquired immune …

Viral infections are known to produce a wide spectrum of immune perturbation, ranging from
a transient and usually innocuous leucopenia to the devastating immunodeficiency of HIV-1 …

Even though an estimated 10–20 million people worldwide are infected with the oncogenic
retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly …

Human T‐cell lymphotropic virus type 1 is transmitted primarily either through sexual
intercourse or from mother to child. The current study investigated sexual transmission and …

It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …